Search Results - "Legnani, C"

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants by Testa, S., Paoletti, O., Legnani, C., Dellanoce, C., Antonucci, E., Cosmi, B., Pengo, V., Poli, D., Morandini, R., Testa, R., Tripodi, A., Palareti, G.

“…Essentials Direct oral anticoagulants (DOACs) do not require laboratory monitoring currently. DOAC specific measurements were performed at trough in patients…”
Get full text

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme by Tripodi, A., Chantarangkul, V., Legnani, C., Testa, S., Tosetto, A.

“…Essentials Tests for direct oral anticoagulants (DOACs) are not widely applied. These tests are perceived to be difficult to run and subjected to large…”
Get full text

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome by PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., BANZATO, A., PADAYATTIL JOSE, S., ILICETO, S.

“…See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary.  Background: The characteristics and the clinical course of antiphospholipid…”
Get full text

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study by Palareti, G., Legnani, C., Cosmi, B., Antonucci, E., Erba, N., Poli, D., Testa, S., Tosetto, A.

“…Summary Introduction D‐dimer assay, generally evaluated according to cutoff points calibrated for VTE exclusion, is used to estimate the individual risk of…”
Get full text

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study by Testa, S., Legnani, C., Tripodi, A., Paoletti, O., Pengo, V., Abbate, R., Bassi, L., Carraro, P., Cini, M., Paniccia, R., Poli, D., Palareti, G.

“…Essentials Prothrombin and partial thromboplastin time (PT/PTT) measure direct oral anticoagulants (DOACs). PT, PTT and specific tests for DOACs were performed…”
Get full text

External validation of the DASH prediction rule: a retrospective cohort study by Tosetto, A., Testa, S., Martinelli, I., Poli, D., Cosmi, B., Lodigiani, C., Ageno, W., De Stefano, V., Falanga, A., Nichele, I., Paoletti, O., Bucciarelli, P., Antonucci, E., Legnani, C., Banfi, E., Dentali, F., Bartolomei, F., Barcella, L., Palareti, G.

“…Essentials Predicting recurrences may guide therapy after unprovoked venous thromboembolism (VTE). We evaluated the DASH score in 827 patients with unprovoked…”
Get full text

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns by Pengo, V., Del Ross, T., Ruffatti, A., Bison, E., Cattini, M.G., Pontara, E., Testa, S., Legnani, C., Pozzi, N., Peterle, D., Acquasaliente, L., De Filippis, V., Denas, G.

“…Whether antibodies directed to β2-Glycoprotein I (aβ2GPI) are responsible for LA activity is not well defined. However, in the absence of such antibodies the…”
Get full text

Management of isolated anterior talofibular ligament lesion in patients suffering from chronic ankle instability: comparison of two minimally invasive surgical techniques by Ventura, A, Terzaghi, C, Macchi, V, Borgo, E, Legnani, C

“…The aim of the present study was to retrospectively compare the outcomes of two minimally invasive surgical techniques in patients with isolated anterior…”
Get more information

The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study: comment by Tripodi, A., Legnani, C., Palareti, G.

Get full text

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism by TRIPODI, A., LEGNANI, C., CHANTARANGKUL, V., COSMI, B., PALARETI, G., MANNUCCI, P. M.

“…Background: The assessment of the risk of recurrent venous thromboembolism (VTE) is important to determine the optimal duration of secondary prophylaxis. The…”
Get full text

The Wells rule and D‐dimer for the diagnosis of isolated distal deep vein thrombosis by SARTORI, M., COSMI, B., LEGNANI, C., FAVARETTO, E., VALDRÉ, L., GUAZZALOCA, G., RODORIGO, G., CINI, M., PALARETI, G.

“…Background:  Pretest clinical probability with the Wells rule and D‐dimer have been widely investigated for the diagnosis of symptomatic proximal deep vein…”
Get full text

Bacterial cellulose membrane as flexible substrate for organic light emitting devices by Legnani, C., Vilani, C., Calil, V.L., Barud, H.S., Quirino, W.G., Achete, C.A., Ribeiro, S.J.L., Cremona, M.

“…Bacterial cellulose (BC) membranes produced by gram-negative, acetic acid bacteria ( Gluconacetobacter xylinus), were used as flexible substrates for the…”
Get full text

Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study by Tripodi, A., Chantarangkul, V., Cini, M., Devreese, K., Dlott, J. S, Giacomello, R., Gray, E., Legnani, C., Martinuzzo, M. E., Pradella, P., Siegemund, A., Subramanian, S., Suchon, P., Testa, S.

“…Essentials Between‐lab variations of cut‐off values in lupus anticoagulant detection are unknown. Cut‐off values were calculated in 11 labs each testing plasma…”
Get full text

White OLED based on a temperature sensitive Eu3+/Tb3+ β-diketonate complex by Lima, P.P., Paz, F.A.A., Brites, C.D.S., Quirino, W.G., Legnani, C., Costa e Silva, M., Ferreira, R.A.S., Júnior, S.A., Malta, O.L., Cremona, M., Carlos, L.D.

“…[Display omitted] •New Eu3+/Tb3+ complex with high emission quantum yield (0.34±0.03) was obtained.•The complex emission intensity is temperature dependent…”
Get full text

HEALTH ECONOMIC EVALUATION OF A DIAGNOSTIC STRATEGY FOR VENOUS THROMBOEMBOLISM by Verma, K, Legnani, C, Palareti, G

Get full text

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain by Besselaar, A. M. H. P., Chantarangkul, V., Angeloni, F., Binder, N. B., Byrne, M., Dauer, R., Gudmundsdottir, B. R., Jespersen, J., Kitchen, S., Legnani, C., Lindahl, T. L., Manning, R. A., Martinuzzo, M., Panes, O., Pengo, V., Riddell, A., Subramanian, S., Szederjesi, A., Tantanate, C., Herbel, P., Tripodi, A.

“…Essentials Two candidate International Standards for thromboplastin (coded RBT/16 and rTF/16) are proposed. International Sensitivity Index (ISI) of proposed…”
Get full text

Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension by COSMI, B., LEGNANI, C., TOSETTO, A., PENGO, V., GHIRARDUZZI, A., TESTA, S., PRISCO, D., POLI, D., TRIPODI, A., PALARETI, G.

“…Background: The PROLONG randomized study showed that patients with an abnormal D‐dimer after anticoagulation suspension for a first unprovoked episode of…”
Get full text

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long‐term recurrence by PALARETI, G., LEGNANI, C., COSMI, B., GUAZZALOCA, G., CINI, M., MATTAROZZI, S.

“…Background and Aim: Several factors are associated with an increased risk of recurrent venous thromboembolism (VTE). The aim of the study was to investigate…”
Get full text

D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis by Cosmi, B, Legnani, C, Cini, M, Guazzaloca, G, Palareti, G

“…D-dimer and residual venous obstruction (RVO) have been separately shown to be risk factors for recurrent venous thromboembolism (VTE) after a first episode of…”
Get more information

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START‐Laboratory Register by Cini, M., Legnani, C., Cosmi, B., Testa, S., Dellanoce, C., Paoletti, O., Marcucci, R., Poli, D., Paniccia, R., Pengo, V., Tripodi, A., Palareti, G.

“…Introduction Several specific assays are commercially available to determine dabigatran anticoagulant activity. Aims of this multicenter and multiplatform…”
Get full text